China Pharma Holdings Inc has been undervalued in the recent couple of years. Here’s another stock that’s highly underrated right now in the market. The potential has huge upside. The current price is .42 just couple of days it was at .29 per share. Chinese penny stocks are less risky comparing to other stocks. Revenue for company is up to 1.17% since 2016. All penny stocks are risky and research is key to being successful.
China Pharma Holding Inc is an US-based drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People’s Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablet, clarithromycin granule, roxithromycin dispersible tablet, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.